VT-122
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VT-122, covering 2015-12-09 to 2015-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) [Phase 2]